Skip to main content
72°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
110.79
-0.15 (-0.14%)
Streaming Delayed Price
Updated: 12:43 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
December 09, 2021
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 12.02% on an annualized basis. Buying $100.00 In ABT: 5 years ago, an investor could have...
Via
Benzinga
This Biotech CEO Is Trying To Cure His Son's Rare Disease
December 09, 2021
Few questions stump Tim Walbert. But the Horizon Therapeutics CEO is still working to answer one of them from his son.
Via
Investor's Business Daily
Watch for Continued Gains in Shares of Abbott Laboratories
December 07, 2021
Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an...
Via
Benzinga
How Did Healthcare Stocks Perform Over This Volatile Month?
December 06, 2021
It’s been a rough month for small-cap biotech stocks amidst a general correction in the market which brought general indices down about 10%.
Via
Talk Markets
Watch for Continued Gains in Shares of Abbott Laboratories
December 06, 2021
Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an...
Via
Benzinga
Abbott and ADA Launch First Joint Community Initiative
December 02, 2021
SOURCE: Abbott
Via
3BL Media
Real Sustainability Is About People
October 29, 2021
SOURCE: Abbott
Via
3BL Media
7 Stocks to Buy to Give Your Portfolio a Booster Shot
December 06, 2021
With the new strain already reported in the U.S., it’s time to consider some adjustments to your portfolio.
Via
InvestorPlace
Exposures
COVID-19
Abbott Labs Stock Climbs Into Top-Performers Group Amid Continued double- and triple-digit Profit, Sales Growth
December 06, 2021
A Relative Strength Rating upgrade for Abbott Laboratories shows improving technical performance.
Via
Investor's Business Daily
Flu, Meet COVID-19: What to Know About This Season
December 06, 2021
SOURCE: Abbott
Via
3BL Media
Topics
Economy
Exposures
COVID-19
Economy
Even Good Penny Stocks Like Senseonics Aren’t Always Profitable
December 03, 2021
Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech.
Via
InvestorPlace
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
December 03, 2021
President Biden announced that private health insurance plans would soon reimburse people who buy over-the-counter (OTC), at-home rapid tests for COVID-19. What Happened...
Via
Benzinga
Exposures
COVID-19
A Lasting Impact Through Better Medicine Adherence
December 03, 2021
SOURCE: Abbott
Via
3BL Media
Topics
Death
Exposures
Death
Notable Abbott Laboratories Insider Trades $5.5M In Company Stock
November 18, 2021
Gregory A Ahlberg, Insider at Abbott Laboratories (NYSE:ABT), made a large buy and sell of company shares on November 15, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Danaher Stock Shows Renewed Strength, Earning Key Rating Hike Amid Rising Profits, Sales
November 18, 2021
A Relative Strength Rating upgrade for Danaher shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Abbott Named to the Corporate Citizenship Hall of Fame
November 18, 2021
SOURCE: Abbott
Via
3BL Media
Better Buy: DexCom or Abbott Labs?
November 17, 2021
Abbott's the heavyweight, and DexCom is the formidable challenger.
Via
The Motley Fool
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...
Via
Benzinga
Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
November 16, 2021
SOURCE: Abbott
Via
3BL Media
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
A (Virtual) Field Trip Into the Heart
November 12, 2021
SOURCE: Abbott
Via
3BL Media
2 Dividend Aristocrats That Could Announce Generous Rate Hikes in December
November 11, 2021
Buy now to take advantage of what will likely be higher yields to come.
Via
The Motley Fool
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
November 09, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced...
Via
FinancialNewsMedia
Exposures
COVID-19
Explore the Human Heart: New Virtual Field Trip Premieres Tuesday, Nov. 9
November 08, 2021
SOURCE: Abbott
Via
3BL Media
10 S&P 500 Stocks to Buy After Winning in Q3
November 05, 2021
Earnings reports for S&P 500 stocks have been exceptionally good so far. Here are 10 stocks to buy that have delivered in Q3.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Engineer Becomes a Mother While Responding to Pandemic
November 05, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023
November 04, 2021
Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Lilly Stock Receives Key IBD Stock Rating Upgrade; Looking To Extend Its Long Run Higher
November 04, 2021
Lilly stock's Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
Via
Investor's Business Daily
7 Dividend Aristocrat Stocks That Should Grace Your Portfolio
November 03, 2021
You get a lot more more from dividend aristocrat stocks than just a rock-solid dividend. They also promise solid, long-term growth.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations
November 03, 2021
SOURCE: Abbott
Via
3BL Media
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.